Alimera Sciences to Present at the H.C. Wainwright Global Life Sciences Conference
Alimera Sciences, Inc. (Nasdaq: ALIM) (“Alimera”), a pharmaceutical
company that specializes in the commercialization and development
of prescription ophthalmology treatments for the management of
retinal diseases, announces that President and CEO Rick Eiswirth
will present at the H.C. Wainwright Global Life Sciences Conference
to be held on March 9-10, 2021.
The presentation will be available on-demand beginning March 9
at 7:00 am ET and be available for 90 days. Investors can view the
presentation by registering for the conference here. Mr. Eiswirth
will be available for virtual one-on-one meetings with investors on
March 9-10, and meeting requests can be made on the conference
website once an investor is registered.
About Alimera Sciences, Inc.
Alimera Sciences is a pharmaceutical company that specializes in
the commercialization and development of prescription ophthalmic
pharmaceuticals. Alimera is presently focused on diseases affecting
the back of the eye, or retina, because these diseases are not well
treated with current therapies and affect millions of people in our
aging populations. For more information, please visit
inquiries:Jules Abrahamfor Alimera
For investor inquiries:Scott Gordonfor Alimera
# # #